1. Home
  2. GKOS vs MHK Comparison

GKOS vs MHK Comparison

Compare GKOS & MHK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • MHK
  • Stock Information
  • Founded
  • GKOS 1998
  • MHK 1988
  • Country
  • GKOS United States
  • MHK United States
  • Employees
  • GKOS N/A
  • MHK N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • MHK Home Furnishings
  • Sector
  • GKOS Health Care
  • MHK Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • MHK Nasdaq
  • Market Cap
  • GKOS 5.8B
  • MHK 6.3B
  • IPO Year
  • GKOS 2015
  • MHK 1992
  • Fundamental
  • Price
  • GKOS $89.83
  • MHK $128.13
  • Analyst Decision
  • GKOS Strong Buy
  • MHK Buy
  • Analyst Count
  • GKOS 12
  • MHK 14
  • Target Price
  • GKOS $131.17
  • MHK $141.79
  • AVG Volume (30 Days)
  • GKOS 1.2M
  • MHK 956.8K
  • Earning Date
  • GKOS 07-30-2025
  • MHK 07-24-2025
  • Dividend Yield
  • GKOS N/A
  • MHK N/A
  • EPS Growth
  • GKOS N/A
  • MHK N/A
  • EPS
  • GKOS N/A
  • MHK 7.53
  • Revenue
  • GKOS $432,953,000.00
  • MHK $10,684,100,000.00
  • Revenue This Year
  • GKOS $27.88
  • MHK N/A
  • Revenue Next Year
  • GKOS $27.76
  • MHK $2.96
  • P/E Ratio
  • GKOS N/A
  • MHK $17.01
  • Revenue Growth
  • GKOS 26.70
  • MHK N/A
  • 52 Week Low
  • GKOS $77.10
  • MHK $96.24
  • 52 Week High
  • GKOS $163.71
  • MHK $164.29
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 43.89
  • MHK 65.18
  • Support Level
  • GKOS $88.94
  • MHK $118.40
  • Resistance Level
  • GKOS $92.70
  • MHK $133.63
  • Average True Range (ATR)
  • GKOS 3.82
  • MHK 3.45
  • MACD
  • GKOS 0.38
  • MHK 0.76
  • Stochastic Oscillator
  • GKOS 46.71
  • MHK 72.80

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About MHK Mohawk Industries Inc.

Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.

Share on Social Networks: